Literature DB >> 31045421

A preliminary investigation of the psychometric properties of PROMIS® scales in emerging adults with sickle cell disease.

Aimee K Hildenbrand1, Charles T Quinn2, Constance A Mara3, James L Peugh3, Emily A McTate3, Maria T Britto4, Lori E Crosby3.   

Abstract

OBJECTIVE: To report preliminary psychometric properties of PROMIS® assessments among emerging adults with sickle cell disease (SCD).
METHOD: Forty-five emerging adults with SCD ages 18-24 (M = 20.81, SD = 1.73) completed PROMIS® Pain Interference and Fatigue short forms and the Pediatric Quality of Life Inventory (PedsQL). Chart review was used to obtain information regarding SCD complications and health care utilization in the 3 years prior to study enrollment. Multivariate path analysis was used to compare PROMIS® scores by disease severity and use of disease-modifying therapies. Cronbach's alpha was used to evaluate internal consistency, and Pearson correlations assessed convergent validity between PROMIS® measures and the PedsQL.
RESULTS: Internal consistency was excellent for PROMIS® Pain Interference (α = .95) and good for PROMIS® Fatigue (α = .85). Associations between PROMIS® measures and PedsQL subscales were in the expected direction and large in magnitude (all ps < .001). There were no differences in PROMIS® scores based on disease severity or use of disease-modifying therapy (ps = .14-.86).
CONCLUSIONS: Findings provide preliminary evidence of validity and reliability of the PROMIS® Pain Interference and Fatigue short forms among emerging adults with SCD. Additional research is needed to replicate these findings in larger samples and assess sensitivity to change over time. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Year:  2019        PMID: 31045421      PMCID: PMC6501803          DOI: 10.1037/hea0000696

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  21 in total

1.  Emerging adulthood. A theory of development from the late teens through the twenties.

Authors:  J J Arnett
Journal:  Am Psychol       Date:  2000-05

2.  The PedsQL 4.0 Generic Core Scales Young Adult Version: feasibility, reliability and validity in a university student population.

Authors:  James W Varni; Christine A Limbers
Journal:  J Health Psychol       Date:  2009-05

Review 3.  The natural history of sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

4.  The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.

Authors:  David Cella; William Riley; Arthur Stone; Nan Rothrock; Bryce Reeve; Susan Yount; Dagmar Amtmann; Rita Bode; Daniel Buysse; Seung Choi; Karon Cook; Robert Devellis; Darren DeWalt; James F Fries; Richard Gershon; Elizabeth A Hahn; Jin-Shei Lai; Paul Pilkonis; Dennis Revicki; Matthias Rose; Kevin Weinfurt; Ron Hays
Journal:  J Clin Epidemiol       Date:  2010-08-04       Impact factor: 6.437

5.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

6.  Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium.

Authors:  Carlton Dampier; Petra LeBeau; Seungshin Rhee; Susan Lieff; Karen Kesler; Samir Ballas; Zora Rogers; Winfred Wang
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

7.  Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease.

Authors:  Carlton Dampier; Vaughn Barry; Heather E Gross; Yang Lui; Courtney D Thornburg; Darren A DeWalt; Bryce B Reeve
Journal:  Pediatr Blood Cancer       Date:  2016-02-19       Impact factor: 3.167

8.  Sickle cell disease related mortality in the United States (1999-2009).

Authors:  Dima Hamideh; Ofelia Alvarez
Journal:  Pediatr Blood Cancer       Date:  2013-04-23       Impact factor: 3.167

9.  Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.

Authors:  San Keller; Manshu Yang; Marsha J Treadwell; Kathryn L Hassell
Journal:  Health Qual Life Outcomes       Date:  2017-06-02       Impact factor: 3.186

Review 10.  Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease.

Authors:  Grammati Sarri; Menaka Bhor; Seye Abogunrin; Caroline Farmer; Savita Nandal; Rashid Halloway; Dennis A Revicki
Journal:  Health Qual Life Outcomes       Date:  2018-05-21       Impact factor: 3.186

View more
  4 in total

1.  Application of validated mapping algorithms between generic PedsQL scores and utility values to individuals with sickle cell disease.

Authors:  Boshen Jiao; Jane S Hankins; Beth Devine; Martha Barton; M Bender; Anirban Basu
Journal:  Qual Life Res       Date:  2022-06-17       Impact factor: 3.440

2.  Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study.

Authors:  Sherif M Badawy; Kaleab Z Abebe; Charlotte A Reichman; Grace Checo; Megan E Hamm; Jennifer Stinson; Chitra Lalloo; Patrick Carroll; Santosh L Saraf; Victor R Gordeuk; Payal Desai; Nirmish Shah; Darla Liles; Cassandra Trimnell; Charles R Jonassaint
Journal:  JMIR Res Protoc       Date:  2021-05-14

3.  Assessing sleep and pain among adults with myalgic encephalomyelitis/chronic fatigue syndrome: psychometric evaluation of the PROMIS® sleep and pain short forms.

Authors:  Manshu Yang; San Keller; Jin-Mann S Lin
Journal:  Qual Life Res       Date:  2022-07-27       Impact factor: 3.440

4.  Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective.

Authors:  Francesca Rodigari; Giorgia Brugnera; Raffaella Colombatti
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.